Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Jesse Schold to Risk Factors

This is a "connection" page, showing publications Jesse Schold has written about Risk Factors.

 
Connection Strength
  
 
 
2.103
  
  1. Brosi D, Wainstein M, Cervantes L, Schold JD. Global perspectives on transplant disparities. Curr Opin Organ Transplant. 2025 Apr 01; 30(2):107-113.
    View in: PubMed
    Score: 0.088
  2. Forman LM, Jackson WE, Arrigain S, Lopez R, Schold JD. Socioeconomic deprivation is associated with worse patient and graft survival following adult liver transplantation. Liver Transpl. 2025 Feb 01; 31(2):211-220.
    View in: PubMed
    Score: 0.085
  3. Zubkov MR, Moore HB, Lopez R, Brosi D, Choudhury RA, Arrigain S, Saben J, Conzen KD, Pomposelli JJ, Pomfret EA, Schold JD. Prognostic value of body mass index is highly modified by sex among recipients of liver transplant. Liver Transpl. 2024 Sep 01; 30(9):962-966.
    View in: PubMed
    Score: 0.084
  4. Schold JD, Huml AM, Husain SA, Poggio ED, Buchalter RB, Lopez R, Kaplan B, Mohan S. Deceased donor kidneys from higher distressed communities are significantly less likely to be utilized for transplantation. Am J Transplant. 2023 11; 23(11):1723-1732.
    View in: PubMed
    Score: 0.078
  5. Amdani S, Tang A, Schold JD. Children from socioeconomically disadvantaged communities present in more advanced heart failure at the time of transplant listing. J Heart Lung Transplant. 2023 02; 42(2):150-155.
    View in: PubMed
    Score: 0.075
  6. Man S, Bruckman D, Tang AS, Uchino K, Schold JD. The Association of Socioeconomic Status and Discharge Destination with 30-Day Readmission after Ischemic Stroke. J Stroke Cerebrovasc Dis. 2021 Dec; 30(12):106146.
    View in: PubMed
    Score: 0.071
  7. Mohan S, King KL, Husain SA, Schold JD. COVID-19-Associated Mortality among Kidney Transplant Recipients and Candidates in the United States. Clin J Am Soc Nephrol. 2021 11; 16(11):1695-1703.
    View in: PubMed
    Score: 0.070
  8. Tsuang WM, Arrigain S, Lopez R, Snair M, Budev M, Schold JD. Patient Travel Distance and Post Lung Transplant Survival in the United States: A Cohort Study. Transplantation. 2020 11; 104(11):2365-2372.
    View in: PubMed
    Score: 0.066
  9. Schold JD, Augustine JJ, Huml AM, Fatica R, Nurko S, Wee A, Poggio ED. Effects of body mass index on kidney transplant outcomes are significantly modified by patient characteristics. Am J Transplant. 2021 02; 21(2):751-765.
    View in: PubMed
    Score: 0.065
  10. Hsich EM, Blackstone EH, Thuita L, McNamara DM, Rogers JG, Ishwaran H, Schold JD. Sex Differences in Mortality Based on United Network for Organ Sharing Status While Awaiting Heart Transplantation. Circ Heart Fail. 2017 Jun; 10(6).
    View in: PubMed
    Score: 0.052
  11. Schold JD, Elfadawy N, Buccini LD, Goldfarb DA, Flechner SM, P Phelan M, Poggio ED. Emergency Department Visits after Kidney Transplantation. Clin J Am Soc Nephrol. 2016 Apr 07; 11(4):674-83.
    View in: PubMed
    Score: 0.048
  12. Schold J, Poggio E, Goldfarb D, Kayler L, Flechner S. Clinical outcomes associated with induction regimens among retransplant kidney recipients in the United States. Transplantation. 2015 Jun; 99(6):1165-71.
    View in: PubMed
    Score: 0.045
  13. Schold JD, Buccini LD, Goldfarb DA, Flechner SM, Poggio ED, Sehgal AR. Association between kidney transplant center performance and the survival benefit of transplantation versus dialysis. Clin J Am Soc Nephrol. 2014 Oct 07; 9(10):1773-80.
    View in: PubMed
    Score: 0.043
  14. Heaphy EL, Poggio ED, Flechner SM, Goldfarb DA, Askar M, Fatica R, Srinivas TR, Schold JD. Risk factors for retransplant kidney recipients: relisting and outcomes from patients' primary transplant. Am J Transplant. 2014 Jun; 14(6):1356-67.
    View in: PubMed
    Score: 0.042
  15. Schold JD, Goldfarb DA, Buccini LD, Rodrigue JR, Mandelbrot D, Heaphy EL, Fatica RA, Poggio ED. Hospitalizations following living donor nephrectomy in the United States. Clin J Am Soc Nephrol. 2014 Feb; 9(2):355-65.
    View in: PubMed
    Score: 0.041
  16. Schold JD, Heaphy EL, Buccini LD, Poggio ED, Srinivas TR, Goldfarb DA, Flechner SM, Rodrigue JR, Thornton JD, Sehgal AR. Prominent impact of community risk factors on kidney transplant candidate processes and outcomes. Am J Transplant. 2013 Sep; 13(9):2374-83.
    View in: PubMed
    Score: 0.040
  17. Heaphy ELG, Goldfarb DA, Poggio ED, Buccini LD, Flechner SM, Schold JD. The impact of deceased donor kidney risk significantly varies by recipient characteristics. Am J Transplant. 2013 Apr; 13(4):1001-1011.
    View in: PubMed
    Score: 0.039
  18. Schold JD, Segev DL. Increasing the pool of deceased donor organs for kidney transplantation. Nat Rev Nephrol. 2012 Mar 27; 8(6):325-31.
    View in: PubMed
    Score: 0.036
  19. Kayler LK, Srinivas TR, Schold JD. Influence of CIT-induced DGF on kidney transplant outcomes. Am J Transplant. 2011 Dec; 11(12):2657-64.
    View in: PubMed
    Score: 0.035
  20. Kayler LK, Magliocca J, Zendejas I, Srinivas TR, Schold JD. Impact of cold ischemia time on graft survival among ECD transplant recipients: a paired kidney analysis. Am J Transplant. 2011 Dec; 11(12):2647-56.
    View in: PubMed
    Score: 0.035
  21. Schold JD, Gregg JA, Harman JS, Hall AG, Patton PR, Meier-Kriesche HU. Barriers to evaluation and wait listing for kidney transplantation. Clin J Am Soc Nephrol. 2011 Jul; 6(7):1760-7.
    View in: PubMed
    Score: 0.034
  22. Braun WE, Schold JD. Transplantation: strength in numbers-predicting long-term transplant outcomes. Nat Rev Nephrol. 2011 Mar; 7(3):135-6.
    View in: PubMed
    Score: 0.034
  23. Buote NJ, Kovak-McClaran JR, Schold JD. Conversion from diagnostic laparoscopy to laparotomy: risk factors and occurrence. Vet Surg. 2011 Jan; 40(1):106-14.
    View in: PubMed
    Score: 0.033
  24. Srinivas TR, Stephany BR, Budev M, Mason DP, Starling RC, Miller C, Goldfarb DA, Flechner SM, Poggio ED, Schold JD. An emerging population: kidney transplant candidates who are placed on the waiting list after liver, heart, and lung transplantation. Clin J Am Soc Nephrol. 2010 Oct; 5(10):1881-6.
    View in: PubMed
    Score: 0.033
  25. Schold JD, Kaplan B. The elephant in the room: failings of current clinical endpoints in kidney transplantation. Am J Transplant. 2010 May; 10(5):1163-6.
    View in: PubMed
    Score: 0.032
  26. Schold JD, Santos A, Rehman S, Magliocca J, Meier-Kriesche HU. The success of continued steroid avoidance after kidney transplantation in the US. Am J Transplant. 2009 Dec; 9(12):2768-76.
    View in: PubMed
    Score: 0.031
  27. Schold JD, Meier-Kriesche HU. Comparable barriers to access to kidney transplantation across national lines. Transplantation. 2009 Jul 15; 88(1):21-2.
    View in: PubMed
    Score: 0.030
  28. Schold J, Srinivas TR, Sehgal AR, Meier-Kriesche HU. Half of kidney transplant candidates who are older than 60 years now placed on the waiting list will die before receiving a deceased-donor transplant. Clin J Am Soc Nephrol. 2009 Jul; 4(7):1239-45.
    View in: PubMed
    Score: 0.030
  29. Schold JD, Rehman S, Kayle LK, Kayler LK, Magliocca J, Srinivas TR, Meier-Kriesche HU. Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transpl Int. 2009 Jun; 22(6):626-34.
    View in: PubMed
    Score: 0.029
  30. Kayler LK, Garzon P, Magliocca J, Fujita S, Kim RD, Hemming AW, Howard R, Schold JD. Outcomes and utilization of kidneys from deceased donors with acute kidney injury. Am J Transplant. 2009 Feb; 9(2):367-73.
    View in: PubMed
    Score: 0.029
  31. Schold JD, Kaplan B, Baliga RS, Meier-Kriesche HU. The broad spectrum of quality in deceased donor kidneys. Am J Transplant. 2005 Apr; 5(4 Pt 1):757-65.
    View in: PubMed
    Score: 0.022
  32. Abidi MZ, Lopez R, Arrigain S, Weinberg A, Kaplan B, McAdams-DeMarco M, Schold JD, Erlandson KM. Area-Level Social Deprivation and Cytomegalovirus Seropositivity at the Time of Solid Organ Transplant. JAMA Netw Open. 2024 Oct 01; 7(10):e2437878.
    View in: PubMed
    Score: 0.022
  33. Wehrle CJ, Gross A, Fares S, Kusakabe J, Calderon E, Shanmugarajah K, Uysal M, Fleischer CM, Allkushi E, Schold JD, Khalil M, Pita A, Fujiki M, Schlegel A, Miller C, Hashimoto K, Wakam GK. Changing Landscape of Open Offers in Liver Transplantation in the Machine Perfusion Era: Exposure, Equity, and Economics. Clin Transplant. 2024 Oct; 38(10):e70012.
    View in: PubMed
    Score: 0.022
  34. Yu M, King KL, Maclay LM, Husain SA, Schold JD, Mohan S. Incomplete reporting of clinically significant acute rejection episodes in the national kidney transplant registry. Am J Transplant. 2024 Oct; 24(10):1828-1836.
    View in: PubMed
    Score: 0.021
  35. Husain SA, Khanna S, Yu M, Adler JT, Cron DC, King KL, Schold JD, Mohan S. Cold Ischemia Time and Delayed Graft Function in Kidney Transplantation: A Paired Kidney Analysis. Transplantation. 2024 09 01; 108(9):e245-e253.
    View in: PubMed
    Score: 0.021
  36. Cooper M, Wiseman AC, Doshi MD, Hall IE, Parsons RF, Pastan S, Reddy KS, Schold JD, Mohan S, Hippen BE. Understanding Delayed Graft Function to Improve Organ Utilization and Patient Outcomes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. Am J Kidney Dis. 2024 03; 83(3):360-369.
    View in: PubMed
    Score: 0.020
  37. Lehr CJ, Schold JD, Arrigain S, Valapour M. New OPTN/UNOS data demonstrates higher than previously reported waitlist mortality for lung transplant candidates supported with ECMO. J Heart Lung Transplant. 2023 10; 42(10):1399-1407.
    View in: PubMed
    Score: 0.020
  38. Koval CE, Eltemamy M, Poggio ED, Schold JD, Wee AC. Comparative outcomes for over 100 deceased donor kidney transplants from SARS-CoV-2 positive donors: A single-center experience. Am J Transplant. 2022 12; 22(12):2903-2911.
    View in: PubMed
    Score: 0.019
  39. AlHilli MM, Schold JD, Kelley J, Tang AS, Michener CM. Preoperative assessment using the five-factor modified frailty index: A call for standardized preoperative assessment and prehabilitation services in gynecologic oncology. Gynecol Oncol. 2022 09; 166(3):379-388.
    View in: PubMed
    Score: 0.019
  40. Amdani S, Marino BS, Rossano J, Lopez R, Schold JD, Tang WHW. Burden of Pediatric Heart?Failure in the United States. J Am Coll Cardiol. 2022 05 17; 79(19):1917-1928.
    View in: PubMed
    Score: 0.018
  41. Abbatemarco JR, Carlson A, Ontaneda D, McGinley M, Bermel RA, Husak S, Bruckman D, Schold JD, Miller DM. Association of socioeconomic disadvantage and neighborhood disparities with clinical outcomes in multiple sclerosis patients. Mult Scler Relat Disord. 2022 May; 61:103734.
    View in: PubMed
    Score: 0.018
  42. Uffing A, P?rez-Sa?z MJ, Jouve T, Bugnazet M, Malvezzi P, Muhsin SA, Lafargue MC, Reindl-Schwaighofer R, Morlock A, Oberbauer R, Buxeda A, Burballa C, Pascual J, von Moos S, Seeger H, La Manna G, Comai G, Bini C, Russo LS, Farouk S, Nissaisorakarn P, Patel H, Agrawal N, Mastroianni-Kirsztajn G, Mansur J, Tedesco-Silva H, Ventura CG, Agena F, David-Neto E, Akalin E, Alani O, Mazzali M, Manfro RC, Bauer AC, Wang AX, Cheng XS, Schold JD, Berger SP, Cravedi P, Riella LV. Recurrence of IgA Nephropathy after Kidney Transplantation in Adults. Clin J Am Soc Nephrol. 2021 08; 16(8):1247-1255.
    View in: PubMed
    Score: 0.017
  43. Augustine JJ, Arrigain S, Mandelbrot DA, Schold JD, Poggio ED. Factors Associated With Residual Kidney Function and Proteinuria After Living Kidney Donation in the United States. Transplantation. 2021 02 01; 105(2):372-381.
    View in: PubMed
    Score: 0.017
  44. Man S, Tang AS, Schold JD, Kolikonda MK, Uchino K. The Patterns and Outcomes of Inter-Hospital Transfer Among Medicare Patients with Ischemic Stroke. J Stroke Cerebrovasc Dis. 2020 Dec; 29(12):105331.
    View in: PubMed
    Score: 0.016
  45. Klein EA, Li J, Milinovich A, Schold JD, Sharifi N, Kattan MW, Jehi L. Androgen Deprivation Therapy in Men with Prostate Cancer Does Not Affect Risk of Infection with SARS-CoV-2. J Urol. 2021 02; 205(2):441-443.
    View in: PubMed
    Score: 0.016
  46. Azem R, Daou R, Bassil E, Anvari EM, Taliercio JJ, Arrigain S, Schold JD, Vachharajani T, Nally J, Na Khoul GN. Serum magnesium, mortality and disease progression in chronic kidney disease. BMC Nephrol. 2020 02 12; 21(1):49.
    View in: PubMed
    Score: 0.016
  47. Man S, Schold JD, Uchino K. Case Fatality Decline from 2009 to 2013 among Medicare Beneficiaries with Ischemic Stroke. J Stroke Cerebrovasc Dis. 2020 Feb; 29(2):104559.
    View in: PubMed
    Score: 0.016
  48. Lehr CJ, Lopez R, Arrigain S, Schold J, Koval C, Valapour M. The impact of change in definition of increased-risk donors on survival after lung transplant. J Thorac Cardiovasc Surg. 2020 Aug; 160(2):572-581.
    View in: PubMed
    Score: 0.015
  49. Saeed F, Arrigain S, Schold JD, Nally JV, Navaneethan SD. What are the Risk Factors for One-Year Mortality in Older Patients with Chronic Kidney Disease? An Analysis of the Cleveland Clinic CKD Registry. Nephron. 2019; 141(2):98-104.
    View in: PubMed
    Score: 0.014
  50. Johnson RJ, Perez-Pozo SE, Lillo JL, Grases F, Schold JD, Kuwabara M, Sato Y, Hernando AA, Garcia G, Jensen T, Rivard C, Sanchez-Lozada LG, Roncal C, Lanaspa MA. Fructose increases risk for kidney stones: potential role in metabolic syndrome and heat stress. BMC Nephrol. 2018 11 08; 19(1):315.
    View in: PubMed
    Score: 0.014
  51. Navaneethan SD, Schold JD, Walther CP, Arrigain S, Jolly SE, Virani SS, Winkelmayer WC, Nally JV. High-density lipoprotein cholesterol and causes of death in chronic kidney disease. J Clin Lipidol. 2018 Jul - Aug; 12(4):1061-1071.e7.
    View in: PubMed
    Score: 0.014
  52. Rincon-Choles H, Jolly SE, Arrigain S, Konig V, Schold JD, Nakhoul G, Navaneethan SD, Nally JV, Rothberg MB. Impact of Uric Acid Levels on Kidney Disease Progression. Am J Nephrol. 2017; 46(4):315-322.
    View in: PubMed
    Score: 0.013
  53. O'Connell PJ, Kuypers DR, Mannon RB, Abecassis M, Chadban SJ, Gill JS, Murphy B, Nickerson PW, Schold JD, Stock PG, Seron D, Alloway RR, Bromberg JS, Budde K, Jordan SC, Legendre C, Lefaucheur C, Sarwall M, Segev DL, Stegall MD, Tullius SG, Wong G, Woodle ES, Ascher N, Morris RE. Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in Direction. Transplantation. 2017 07; 101(7):1527-1534.
    View in: PubMed
    Score: 0.013
  54. Lentine KL, Lam NN, Schnitzler MA, Hess GP, Kasiske BL, Xiao H, Axelrod D, Garg AX, Schold JD, Randall H, Dzebisashvili N, Brennan DC, Segev DL. Predonation Prescription Opioid Use: A Novel Risk Factor for Readmission After Living Kidney Donation. Am J Transplant. 2017 03; 17(3):744-753.
    View in: PubMed
    Score: 0.012
  55. Dalton JE, Zidar DA, Udeh BL, Patel MR, Schold JD, Dawson NV. Practice Variation Among Hospitals in Revascularization Therapy and Its Association With Procedure-related Mortality. Med Care. 2016 06; 54(6):623-31.
    View in: PubMed
    Score: 0.012
  56. Snyder JJ, Salkowski N, Wey A, Israni AK, Schold JD, Segev DL, Kasiske BL. Effects of High-Risk Kidneys on Scientific Registry of Transplant Recipients Program Quality Reports. Am J Transplant. 2016 09; 16(9):2646-53.
    View in: PubMed
    Score: 0.012
  57. Lentine KL, Lam NN, Axelrod D, Schnitzler MA, Garg AX, Xiao H, Dzebisashvili N, Schold JD, Brennan DC, Randall H, King EA, Segev DL. Perioperative Complications After Living Kidney Donation: A National Study. Am J Transplant. 2016 06; 16(6):1848-57.
    View in: PubMed
    Score: 0.012
  58. Navaneethan SD, Schold JD, Huang H, Nakhoul G, Jolly SE, Arrigain S, Dweik RA, Nally JV. Mortality Outcomes of Patients with Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease. Am J Nephrol. 2016; 43(1):39-46.
    View in: PubMed
    Score: 0.012
  59. Navaneethan SD, Schold JD, Arrigain S, Kirwan JP, Nally JV. Body mass index and causes of death in chronic kidney disease. Kidney Int. 2016 Mar; 89(3):675-82.
    View in: PubMed
    Score: 0.012
  60. Nakhoul GN, Schold JD, Arrigain S, Harb SC, Jolly S, Wilkoff BL, Nally JV, Navaneethan SD. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis. Clin J Am Soc Nephrol. 2015 Jul 07; 10(7):1119-27.
    View in: PubMed
    Score: 0.011
  61. Toledo C, Thomas G, Schold JD, Arrigain S, Gornik HL, Nally JV, Navaneethan SD. Renal resistive index and mortality in chronic kidney disease. Hypertension. 2015 Aug; 66(2):382-8.
    View in: PubMed
    Score: 0.011
  62. Navaneethan SD, Wehbe E, Heresi GA, Gaur V, Minai OA, Arrigain S, Nally JV, Schold JD, Rahman M, Dweik RA. Presence and outcomes of kidney disease in patients with pulmonary hypertension. Clin J Am Soc Nephrol. 2014 May; 9(5):855-63.
    View in: PubMed
    Score: 0.010
  63. Elfadawy N, Flechner SM, Schold JD, Srinivas TR, Poggio E, Fatica R, Avery R, Mossad SB. Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation. Clin J Am Soc Nephrol. 2014 Mar; 9(3):553-61.
    View in: PubMed
    Score: 0.010
  64. Elfadawy N, Flechner SM, Liu X, Schold J, Srinivas TR, Poggio E, Fatica R, Avery R, Mossad SB. CMV Viremia is associated with a decreased incidence of BKV reactivation after kidney and kidney-pancreas transplantation. Transplantation. 2013 Dec 27; 96(12):1097-103.
    View in: PubMed
    Score: 0.010
  65. Sakhuja A, Schold JD, Kumar G, Katzan I, Navaneethan SD. Nontraumatic subarachnoid hemorrhage in maintenance dialysis hospitalizations: trends and outcomes. Stroke. 2014 Jan; 45(1):71-6.
    View in: PubMed
    Score: 0.010
  66. Rodrigue JR, Schold JD, Mandelbrot DA. The decline in living kidney donation in the United States: random variation or cause for concern? Transplantation. 2013 Nov 15; 96(9):767-73.
    View in: PubMed
    Score: 0.010
  67. Kayler LK, Wen X, Zachariah M, Casey M, Schold J, Magliocca J. Outcomes and survival analysis of old-to-old simultaneous pancreas and kidney transplantation. Transpl Int. 2013 Oct; 26(10):963-72.
    View in: PubMed
    Score: 0.010
  68. Navaneethan SD, Schold JD, Kirwan JP, Arrigain S, Jolly SE, Poggio ED, Beddhu S, Nally JV. Metabolic syndrome, ESRD, and death in CKD. Clin J Am Soc Nephrol. 2013 Jun; 8(6):945-52.
    View in: PubMed
    Score: 0.010
  69. Navaneethan SD, Schold JD, Arrigain S, Thomas G, Jolly SE, Poggio ED, Schreiber MJ, Sarnak MJ, Nally JV. Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease. Nephrol Dial Transplant. 2012 Aug; 27(8):3228-34.
    View in: PubMed
    Score: 0.009
  70. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Wehbe E, Raina R, Simon JF, Srinivas TR, Jain A, Schreiber MJ, Nally JV. Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease. Clin J Am Soc Nephrol. 2011 Oct; 6(10):2395-402.
    View in: PubMed
    Score: 0.009
  71. Demirjian S, Teo BW, Guzman JA, Heyka RJ, Paganini EP, Fissell WH, Schold JD, Schreiber MJ. Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transplant. 2011 Nov; 26(11):3508-14.
    View in: PubMed
    Score: 0.008
  72. Ejaz AA, Beaver TM, Shimada M, Sood P, Lingegowda V, Schold JD, Kim T, Johnson RJ. Uric acid: a novel risk factor for acute kidney injury in high-risk cardiac surgery patients? Am J Nephrol. 2009; 30(5):425-9.
    View in: PubMed
    Score: 0.008
  73. Meier-Kriesche HU, Schold JD, Vanrenterghem Y, Halloran PF, Ekberg H. Uric acid levels have no significant effect on renal function in adult renal transplant recipients: evidence from the symphony study. Clin J Am Soc Nephrol. 2009 Oct; 4(10):1655-60.
    View in: PubMed
    Score: 0.008
  74. Bihorac A, Yavas S, Subbiah S, Hobson CE, Schold JD, Gabrielli A, Layon AJ, Segal MS. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg. 2009 May; 249(5):851-8.
    View in: PubMed
    Score: 0.007
  75. Hobson CE, Yavas S, Segal MS, Schold JD, Tribble CG, Layon AJ, Bihorac A. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009 May 12; 119(18):2444-53.
    View in: PubMed
    Score: 0.007
  76. Lansang MC, Ma L, Schold JD, Meier-Kriesche HU, Kaplan B. The relationship between diabetes and infectious hospitalizations in renal transplant recipients. Diabetes Care. 2006 Jul; 29(7):1659-60.
    View in: PubMed
    Score: 0.006
  77. Reddy V, Winer AG, Eksioglu E, Meier-Kriesche HU, Schold JD, Wingard JR. Interleukin 12 is associated with reduced relapse without increased incidence of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005 Dec; 11(12):1014-21.
    View in: PubMed
    Score: 0.006
  78. Reddy V, Meier-Kriesche HU, Greene S, Schold JD, Wingard JR. Increased levels of tumor necrosis factor alpha are associated with an increased risk of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005 Sep; 11(9):698-705.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)